IBanga le-Pharmaceutical 1392275-56-7 I-Tenofovir alafenamide fumarate yoNyango lwe-Hepatitis B engapheliyo

Inkcazelo emfutshane:

Ubunyulu:≧98%, Mhlophe okanye ngaphandle komgubo omhlophe

Isatifikethi:I-COA, i-MOA, i-MSDS, njl

Umthamo:50Kgs/ngenyanga

Beka ubomi kwishelufa:iminyaka eyi-2

Isicelo:intsholongwane yehepatitis B nucleotide reverse transcriptase inhibitor kunyango lwehepatitis B

Iqela eliluncedo:Iqela lokuthengisa izinto ezithunyelwa ngaphandle elinamava kunye nololiwe ochwepheshile kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Imvelisoigama	I-Tenofovir alafenamide fumarate
Izithethantonye	N-[(S)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-methylethyl ester (2E)-2 -butenedioate ( 2:1 );GS 7340-03
Inombolo yeCAS.	1392275-56-7
Imbonakalo	Umgubo omhlophe okanye ophantse umhlophe wekristale
Ifomula yeemolekyuli	2(C₂₁H₂₉N₆O₅P).C₄H₄O₄
Ubunzima beMolekyuli	1069.02
Ukusetyenziswa	IBanga lezoKhemesti ngenjongo yoPhando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf